Genetic markers of polycystic ovary syndrome: role in the pathogenesis and phenotypic manifestations of the disease
https://doi.org/10.33667/2078-5631-2022-24-44-47
Abstract
Polycystic ovary syndrome is currently regarded as a multifactorial disease with a genetic predisposition, characterized by a wide variability in clinical manifestations that affect the reproductive, endocrine and metabolic functions of women. Despite the great scientific interest in this pathology, the causes and mechanisms of development remain not fully understood. In this article, we reviewed the most current research on the genetic markers of PCOS.
About the Authors
A. B. Khuraseva
Kursk State Medical University
Russian Federation
Russian Federation
Khuraseva Anna B., DM Sci (habil.), professor, Department of Obstetrics and Gynecology Institute of Continuing Education
Kursk
K. S. Svyatchenko
Zhivitsa Medical Center
Russian Federation
Russian Federation
Svyatchenko Ksenia S., obstetrician-gynecologist
Kursk
References
1. Kulakov V. I. Gynecology: national leadership (in English) / ed. V. I. Kulakov, I. B. Manukhin, G. M. Savelieva. – M.: GEOTAR-Media, 2011. – 1088 p. ISBN 978-5-9704-1897-0.
2. Molecular-genetic aspects of the formation of polycystic ovary syndrome phenotypes in adolescent girls (in English) / D. M. Lukyanova, E. P. Khashchenko, E. V. Uvarova // Reproductive health of children and adolescents. – 2015. – No. 5. – P. 46–55
3. Hyperandrogenism syndrome in the practice of an obstetrician-gynecologist, dermatologist and endocrinologist: modern aspects of pathogenesis, diagnosis and therapy (in English) / Yu. E. Dobrokhotova, E. M. Dzhobava, Z. E. Rahimova, M. Yu. Gerasimovich. –M.: GEOTAR-Media, 2009. – 112 p. ISBN 978-5-9704-1393-7.
4. Polycystic ovary syndrome in reproductive age: modern views on the pathogenesis and clinical manifestations (in English) / O. V. Paramonova, E. G. Korenskaya, A. S. Trofimenko, I. A. Zborovskaya // Problems of Women’s Health. – 2013. – V. 8, No. 2. – P. 74–80.
5. PCOS: from reconsideration to new therapeutic strategies. Modernscientific data and clinical guidelines of the Ministry of Health of the Russian Federation 2015. Newsletter (in English) / ed. E. N. Andreeva, M. B. Khamoshina. – M.: Editorial office of the journal Status Praesens. – 2016. – 28 p.
6. Heritability of polycystic ovary syndrome in a Dutch twin-family study / Vink J. M., Sadrzadeh S., Lambalk C. B., Boomsma D. I. // J. Clin. Endocrinol. Metab. – 2006. – Vol. 91, No. 6. – Р. 2100–2104. DOI: 10.1210/jc.2005–1494
7. Joseph S., Barai R. S., Bhujbalrao R., Idicula-Thomas S. / PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome // Nucl. Acids Res. – 2015. http://pcoskb.bicnirrh.res.in. doi: 10.1093/nar/gkv1146
8. Endocrine-metabolic features in patients with polycystic ovary syndrome (in English). / G. T. Sukhikh, A. M. Biryukova, T. A. Nazarenko, E. R. Durinyan // Obstetrics and Gynecology. – 2011. – No. 4. – P. 45–49.
9. Molecular genetic aspects of the pathogenesis of PCOS (in English). / E. N. Andreeva, T. V. Semicheva, A. F. Vesnina et al., Probl. reprod. – 2007. – T. 13, No. 6. – P. 29–35.
10. The role of polymorphic genes in the development of polycystic ovary syndrome (in English) / S. S. Shulunov, V. A. Shenin, L. I. Kolesnikova // Sib. med. Magazine. – 2011. –No. 7. – P. 5–8.
11. Lack of association of INS VNTR polymorphism with polycystic ovary syndrome: a meta-analysis/ Song L., Luo J., Peng Q. et al. // Journal of Assisted Reproduction and Genetics. – 2014. Vol. 31, No. 6. – P. 675–681. doi: 10.1007/s10815-014-0211-6
12. Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome / Dilek S., Ertunc D., Tok E. C., Erdal E. M., Aktas A. // Fertil Steril. – 2005. – Vol. 84. – Р. 407–412. DOI: 10.1016/j.fertnstert.2005.01.133
13. Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis / Ioannidis A., Ikonomi E., Dimou N. L. et al. // Mol. Genet. Metab. – 2010. – Vol. 99. No. 2 – Р.174–183. DOI: 10.1016/j.ymgme.2009.10.013
14. Association between fat mass and obesity associated (FTO) gene rs9939609 A/T polymorphism and polycystic ovary syndrome: a systematic review and meta-analysis/Liu A. L., Xie H. J., Xie H. Y. et al. // BMC Med. Genet. 2017;18(1):89. doi.org/10.1186/s12881-017-0452-1
15. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome /Attaoua R., Ait El Mkadem S., Radian S. et al. // Biochem. Biophys. Res. Commun. –2008. –Vol. 373, No. 2. – Р. 230–234. DOI: 10.1016/j.bbrc.2008.06.039
16. Common variant rs9939609 in gene FTO confers risk to polycystic ovary syndrome / Li T, Wu K,, You L, et al. // PLoS One. –2013;8(7). doi: 10.1371/journal.pone.0066250
17. Polycystic Ovary Syndrome: A Guide for Physicians (in English)/ Ed. ed. I. I. Dedova, G. A. Melnichenko. – M.: OOO «Medical Information Agency», 2007. – 368 p.
18. Genetic aspects of the formation of polycystic ovary syndrome (in English) / A. A. Naidukova, E. K. Kaprina, A. E. Donnikov, G. E. Chernukha // Obstetrics and Gynecology. –2016. – No 3. – P. 16–22.
19. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome / Xita N., Georgiou I., Lazaros L. et al. // Hum.Reprod. – 2008. – Vol. 23. – Р. 693–698. DOI: 10.1093/humrep/dem382
20. Klebanova E. M. Adipose tissue hormones and their role in the pathogenesis diabetes of type 2 (in English) / E. M. Klebanova, M. I. Balabolkin // Attending physician. – 2010. –No. 11. – P. 27–33.
21. Kovaleva Yu. V. Hormones of adipose tissue and their role in the formation of hormonal status and the pathogenesis of metabolic disorders in women (in English) / AG. – 2015. –No. 4. – P. 356–370.
22. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 / Chen Z. J., Zhao H., He L. et al. // Nat. Genet. – 2011. – Vol. 43, No. 1. – Р. 55–59. DOI: 10.1038/ng.732
23. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome / Shi Y., Zhao H., Cao Y. et al. // Nat. Genet. – 2012. – Vol. 44, No. 9. – Р. 1020–1025. DOI: 10.1038/ng.2384
24. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome / Day F. R., Hinds D. A., Tung J. Y. et al. // Nat. Сommun. 2015; 6. DOI: 10.1038/ncomms9464
25. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations / Hayes M. G., Urbanek M., Ehrmann D. A. et al. // Nat. Commun. – 2015;6:7502. DOI: 10.1038/ncomms8502
Review
For citations:
Khuraseva A.B., Svyatchenko K.S. Genetic markers of polycystic ovary syndrome: role in the pathogenesis and phenotypic manifestations of the disease. Medical alphabet. 2022;(24):44-47. (In Russ.) https://doi.org/10.33667/2078-5631-2022-24-44-47
Views:
426
Email this article 